event-feature-image

Group Sequential Designs were one of the earliest deviations from a traditional two-arm clinical trial with no interim looks at the data. They still add amazing value to trials through their abilities to safeguard patients, reach positive conclusions early and keep trial designs simple and streamlined. Sample Size Re-estimation is another key tool in the modern trial designer’s toolkit. Join us for a complimentary webinar to learn: the basics of Group Sequential Designs and Sample Size Re-estimation, how they are used and how they can improve trial design. Click below to learn more and register. 

Learn More

June 3
Webinar

Group Sequential Designs and Sample Size Re-estimation - Modern Uses

Group Sequential Designs were one of the earliest deviations from a traditional two-arm clinical trial with no interim looks at the data. They still add amazing value to trials through their abilities to safeguard patients, reach positive conclusions early and keep trial designs simple and streamlined. Sample Size Re-estimation is another key tool in the modern trial designer’s toolkit.

Join us for a complimentary webinar to learn:

  • the basics of Group Sequential Designs and Sample Size Re-estimation
  • how they are used
  • how they can improve trial design

Click below to learn more and register.

June 17
Webinar

Practical Model-based Approaches for Phase I Oncology Trials

Phase I Oncology trials used dose-escalation to determine the maximum tolerated dose for further study. Modern model-based techniques help to acquire knowledge about the chemistry of the new drug and select appropriate dose for later phases. It offers clinicians more flexibility than more traditional designs like the 3+3. Through this introduction to advanced dose escalation methods, you will first learn about the traditional 3+3 method for dose-escalation and then gain an understanding of how Bayesian logistic regression model (BLRM) techniques can improve the traditional method. Click below to register.

July 17
Webinar

Introduction to Population Enrichment Trial Designs

Abstract Coming Soon!
 
This webinar, presented by Thomas Burnett, Senior Research Associate in Medical and Pharmaceutical Statistics, Lancaster University is a part of a webinar series that introduces biostatisticians and other members of the development team to some of the more commonly used complex innovative trial designs, the benefits of each, and the practical considerations for adoption. Click below to learn more about the series and register.

October 20 - 22
Cambridge, MA

Innovations in Bayesian Clinical Trials Symposium and Interactive Workshop

Cytel and Novartis invite you to the Innovations in Bayesian Clinical Trials Symposium and Interactive Workshop. Join industry leaders and academics for a full day of topical presentations followed by a two-day workshop, where participants will learn the fundamentals and applications of Bayesian statistics. Click below to learn more and register. The full agenda will be made available soon.